New Key Statistics Module, Z-Score and F-Score
NAS:FWBI Key Ratios
Market Cap $ M | 5.53 |
Enterprise Value $ M | 3.23 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.18 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -304.48 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 72.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.20 |
EV-to-EBITDA | -0.21 |
PEG | -- |
Shares Outstanding M | 2.03 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 1.58 |
Current Ratio | 1.58 |
ROA % (ttm) | -280.93 |
ROE % (ttm) | -597.44 |
ROIC % (ttm) | -655.43 |
Dividend Yield % | -- |
Altman Z-Score | -- |
FWBI Number of Guru Trades
FWBI Volume of Guru Trades
Gurus Latest Trades with NAS:FWBI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FWBI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
First Wave BioPharma Inc Insider Transactions
No Available Data
News about NAS:FWBI
Total 0- 1